Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
30
NCT00501332
Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy
Phase: Phase 2
Role: Collaborator
Start: Jul 31, 2007
Completion: Not specified